American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Endocrine Practice

• Publication date

  2007-07-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.4158/EP.13.S1.1PMID 17613449
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Homocystinuria, arteriosclerosis, methylmalonic aciduria, and methyltransferase deficiency: a key case revisited.

  2009cited by this paper
• Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.

  2009cited by this paper
• Nutrition Recommendations and Interventions for Diabetes

  2008cited by this paper
• Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

  2008cited by this paper
• Comparison of Vildagliptin and Rosiglitazone Monotherapy in Patients With Type 2 Diabetes

  2007cited by this paper
• beta-cell failure in diabetes and preservation by clinical treatment.

  2007cited by this paper
• Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.

  2007cited by this paper
• Rosiglitazone RECORD study: glucose control outcomes at 18 months

  2007cited by this paper
• Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

  2007cited by this paper
• Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double‐blind, non‐inferiority trial

  2007cited by this paper
• Rosiglitazone and cardiovascular risk.

  2007cited by this paper
• To Err Is Human : Building a Safer Health System

  2007cited by this paper
• Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study

  2006cited by this paper
• Nutrition Recommendations and Interventions for Diabetes–2006

  2006cited by this paper
• Standards of Medical Care in Diabetes: Response to Power

  2006cited by this paper
• India's efforts to boost neonatal survival.

  2006cited by this paper
• Use of a blood glucose monitoring manual to enhance monitoring adherence in adults with diabetes: a randomized controlled trial.

  2006cited by this paper
• Self-monitoring of glucose in type 2 diabetes mellitus:a Bayesian meta-analysis of direct and indirect comparisons

  2006cited by this paper
• Cardiovascular Diabetology BioMed Central Review

  2006cited by this paper
• Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

  2006cited by this paper
• Physical Activity/Exercise and Type 2 Diabetes

  2006cited by this paper
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

  2006cited by this paper
• Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics

  2006cited by this paper
• Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study.

  2006cited by this paper
• Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

  2006cited by this paper
• Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.

  2006cited by this paper
• Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

  2006cited by this paper
• Intensive insulin therapy in the medical ICU.

  2006cited by this paper
• Standards of medical care in diabetes.

  2006cited by this paper
• Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.

  2006cited by this paper
• Correction to the FIELD study report.

  2006cited by this paper
• Decreased mortality by normalizing blood glucose after acute ischemic stroke.

  2006cited by this paper
• Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.

  2006cited by this paper
• Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c.

  2006cited by this paper
• Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

  2006cited by this paper
• Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.

  2006cited by this paper
• Nutrition therapy for the hospitalized patient with diabetes.

  2006cited by this paper
• Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.

  2005influential reference
• Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

  2005cited by this paper
• Glycemic Variability: It's Not Just About A1C Anymore!

  2005cited by this paper
• American College of Endocrinology and American Association of Clinical Endocrinologists position statement on patient safety and medical system errors in diabetes and endocrinology.

  2005cited by this paper
• Effect of different antilipidemic agents and diets on mortality: a systematic review.

  2005cited by this paper
• Combined hypertension and orthostatic hypotension in older patients: a treatment dilemma for clinicians

  2005cited by this paper
• Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004)*

  2005cited by this paper
• Group based training for self-management strategies in people with type 2 diabetes mellitus.

  2005cited by this paper
• Efficacy and safety of ezetimibe co‐administered with simvastatin in thiazolidinedione‐treated type 2 diabetic patients

  2005cited by this paper
• Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.

  2005cited by this paper
• Sex differences in the effect of diabetes duration on coronary heart disease mortality.

  2005cited by this paper
• Preventing foot ulcers in patients with diabetes.

  2005cited by this paper
• Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease.

  2005cited by this paper
• Preventing microalbuminuria in type 2 diabetes.

  2005cited by this paper
• Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.

  2005cited by this paper
• Postprandial Myocardial Perfusion in Healthy Subjects and in Type 2 Diabetic Patients

  2005cited by this paper
• The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study

  2005cited by this paper
• Hyperglycemia in the Hospital

  2005cited by this paper
• Which diabetic patients should receive podiatry care? An objective analysis

  2005cited by this paper
• Carbohydrate bioavailability

  2005cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Effect of lowering of homocysteine levels on inflammatory markers: a randomized controlled trial.

  2005cited by this paper
• Vascular risk factors and diabetic neuropathy.

  2005cited by this paper
• Evaluation of efficacy and safety of fixed dose combination of glimepiride 2 mg pluspioglitazone 15 mg plus metformin SR 500 mg in the management of patients with type-2 diabetes mellitus.

  2005cited by this paper
• New insulin infusion protocol Improves blood glucose control in hospitalized patients without increasing hypoglycemia.

  2005cited by this paper
• Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus.

  2005cited by this paper
• Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes.

  2005cited by this paper
• Comparison of a digital retinal imaging system and seven-field stereo color fundus photography to detect diabetic retinopathy in the primary care environment.

  2005cited by this paper
• Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

  2005cited by this paper
• Structured dietary advice incorporating walnuts achieves optimal fat and energy balance in patients with type 2 diabetes mellitus.

  2005cited by this paper
• Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review.

  2005cited by this paper
• A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.

  2005cited by this paper
• Insulin therapy protects the central and peripheral nervous system of intensive care patients

  2005cited by this paper
• Diabetic neuropathies: a statement by the American Diabetes Association.

  2005cited by this paper
• Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study.

  2005cited by this paper
• Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).

  2005cited by this paper
• Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.

  2005cited by this paper
• Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

  2005cited by this paper
• Rationale for targeting multiple lipid pathways for optimal cardiovascular risk reduction.

  2005cited by this paper
• History and development of plant sterol and stanol esters for cholesterol-lowering purposes.

  2005cited by this paper
• Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia

  2005cited by this paper
• Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff.

  2005cited by this paper
• Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes

  2005cited by this paper
• Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction: Implications for Patients With and Without Recognized Diabetes

  2005cited by this paper
• Incidence of Type 2 Diabetes in the Randomized Multiple Risk Factor Intervention Trial

  2005cited by this paper
• Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.

  2005cited by this paper
• The beneficial effects of pancreas transplant alone on diabetic nephropathy.

  2005cited by this paper
• Technology Evaluation: A Randomized Trial of Electronic Clinical Reminders to Improve Quality of Care for Diabetes and Coronary Artery Disease

  2005cited by this paper
• Five System Barriers to Achieving Ultrasafe Health Care

  2005cited by this paper
• The effect of ruboxistaurin on nephropathy in type 2 diabetes.

  2005cited by this paper
• Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

  2005cited by this paper
• Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

  2005cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• No effect of statin therapy on silent myocardial ischemia in patients with type 2 diabetes without manifest cardiovascular disease.

  2005cited by this paper
• Prevalence of silent myocardial ischemia in persons with diabetes mellitus or impaired glucose tolerance and association of hemoglobin A1c with prevalence of silent myocardial ischemia.

  2005cited by this paper
• The effects of type 1 diabetes on cognitive performance: a meta-analysis.

  2005cited by this paper
• The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature.

  2005cited by this paper
• The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized clinical trial.

  2005cited by this paper
• [The Da Qing IGT and Diabetes study].

  2005cited by this paper
• CLINICAL REVIEW: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy.

  2005cited by this paper
• Cost-related skipping of medications and other treatments among medicare beneficiaries between 1998 and 2000

  2005cited by this paper
• Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes.

  2005cited by this paper
• C-reactive protein levels and outcomes after statin therapy.

  2005cited by this paper

• Development and Evaluation of Empagliflozin-Loaded Solid Lipid Nanoparticles: Pharmacokinetics and Pharmacodynamics for Oral Delivery

  2025cites this paper
• Association Does Not Mean Causation, When Observational Data Were Misinterpreted as Causal: The Observational Interpretation Fallacy.

  2024cites this paper
• Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care.

  2024cites this paper
• Average Carbohydrate and CaLoric Intake of Patients with Type-2 diabetes at a tertiary care hospital in Pakistan: ACCLIP study

  2024influential citation
• Admission blood glucose and 30-day mortality in patients with acute decompensated heart failure: prognostic significance in individuals with and without diabetes

  2024cites this paper
• The association of glycated hemoglobin A1c with coronary artery disease, myocardial infarction, and severity of coronary lesions

  2023cites this paper
• COVID-19 and metabolic syndrome

  2023cites this paper
• Is Type II DM A Risk Factor for Osteoporosis

  2023cites this paper
• The effect of dietary carbohydrate and calorie restriction on weight and metabolic health in overweight/obese individuals: a multi-center randomized controlled trial

  2023cites this paper
• Evolution of Guideline Recommendations on Insulin Therapy in Type 2 Diabetes Mellitus Over the Last Two Decades: A Narrative Review

  2023cites this paper
• Combined low-carbohydrate diet and long-term exercise in hypoxia in type 2 diabetes: A randomized controlled trial protocol to assess glycemic control, cardiovascular risk factors and body composition

  2023cites this paper
• Management of Glucocorticoid-Induced Hyperglycemia Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2022cites this paper
• Adherence to medication and glucose control in diabetic patients in Duhok, Iraq

  2022cites this paper
• Management of Glucocorticoid-Induced Hyperglycemia

  2022cites this paper
• Update on the management of diabetes in long-term care facilities

  2022cites this paper
• A Health Care Professional Delivered Low Carbohydrate Diet Program Reduces Body Weight, Haemoglobin A1c, Diabetes Medication Use and Cardiovascular Risk Markers—A Single-Arm Intervention Analysis

  2022cites this paper
• Social Care Recommendations in National Diabetes Treatment Guidelines

  2022cites this paper
• Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study.

  2022cites this paper
• Comparison of two insulin injection methods on control of type 2 diabetes; is the new protocol effective or not?

  2021influential citation
• Nutritional management of type 2 diabetes in subjects with obesity: an international guideline for clinical practice

  2021cites this paper
• Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.

  2021cites this paper
• Development and evaluation of an integrated diabetes-periodontitis nutrition and health education module

  2021cites this paper
• Admission Hyperglycemia Is a Risk Factor for Deep Surgical-Site Infection in Orthopaedic Trauma Patients

  2021cites this paper
• Sleep Quality and Associated Factors in Adults with Type 2 Diabetes: A Retrospective Cohort Study

  2021cites this paper
• Evaluation of a novel artificial intelligence-based screening system for diabetic retinopathy in community of China: a real-world study

  2021cites this paper
• Glycemic control and its determinants among patients with type 2 diabetes mellitus at Menelik II Referral Hospital, Ethiopia

  2021cites this paper
• Can Newer Anti-Diabetic Therapies Delay the Development of Diabetic Nephropathy?

  2021cites this paper
• Optimizing medical therapy in the coronary artery bypass graft patient

  2021cites this paper
• Use of Insulin Degludec/Insulin Aspart in the Management of Diabetes Mellitus: Expert Panel Recommendations on Appropriate Practice Patterns

  2021cites this paper
• Self-management practices among type 2 diabetes patients attending physicians and pharmacists: An exploratory study from Lahore, Pakistan

  2020cites this paper
• Determination of the daily intake of essential elements in some of medicinal plants used for high blood sugar in traditional medicine of Iran

  2020cites this paper
• System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015

  2020cites this paper
• Postprandial glycemic response of whole peas and lentils and their flours in adults with type 2 diabetes

  2020cites this paper
• Magnitude of missed opportunities for prediabetes screening among non-diabetic adults attending the family practice clinic in Western Nigeria: Implication for diabetes prevention

  2020cites this paper
• Impact of Two Different Reference Measurement Procedures on Apparent System Accuracy of 18 CE-Marked Current-Generation Blood Glucose Monitoring Systems

  2020cites this paper
• Role of Glucagon-Like Peptide-1 Analogues on Obesity and Type-II Diabetes Mellitus: A Review

  2020cites this paper
• Quality of Quality Measures

  2020cites this paper
• Relationship between Lipid Profiles and Glycemic Control Among Patients with Type 2 Diabetes in Qingdao, China

  2020cites this paper
• Method verification procedure of boric acid affinity method against high performance of liquid chromatography for glycated haemoglobin

  2020cites this paper
• Quality Measures: The Revolution in Patient Safety and Outcomes

  2020cites this paper
• SGLT inhibitors as antidiabetic agents: a comprehensive review

  2020cites this paper
• Diabetes Mellitus: An Independent Risk Factor of In-Hospital Mortality in Patients with Infective Endocarditis in a New Era of Clinical Practice

  2019cites this paper
• Prevalence of Type 2 Diabetes Associated Complications ion Kurdistan Region Iraq

  2019influential citation
• Endocrine Diseases of Pregnancy

  2019cites this paper
• Drug Utilization Evaluation of Anti-Diabetic Medication through Prescription Monitoring

  2019cites this paper
• Practice Guidelines for Enteral Nutrition Management in Dysglycemic Critically Ill Patients: A Relook for Indian Scenario

  2019cites this paper
• Impact of gestational diabetes mellitus in maternal and fetal health: An update

  2019cites this paper
• Effectiveness of Health Literacy through Transformative Learning on Glycemic control Behavior in Adult Diabetes Patients: A Mixed Methods Approach

  2019cites this paper
• Comparison of intensive insulin therapy and conventional glucose management in patients undergoing coronary artery bypass grafting

  2019cites this paper
• Perioperative tight glycemic control using artificial pancreas decreases infectious complications via suppression of inflammatory cytokines in patients who underwent pancreaticoduodenectomy: A prospective, non-randomized clinical trial.

  2019cites this paper
• Relationship between hemoglobin A1c and serum troponin in patients with diabetes and cardiovascular events

  2019cites this paper
• Proton pump inhibitors regulate metabolic profile and glycaemic indices in patients with type 2 diabetes mellitus: A rising dawn of a new therapeutic concept.

  2019cites this paper
• Prevalence of Hypoglycemia Among Patients With Type 2 Diabetes Mellitus in a Rural Health Center in South India

  2019cites this paper
• Tip 2 Diyabetli Hastalarda Oral Anti Diyabetik İlaçların HBA1c, Obezite ve Komplikasyonlar ile İlişkisi

  2018cites this paper
• Pioglitazone and cardiovascular risk in T2DM patients: is it good for all?

  2018cites this paper
• The Postprandial-to-Fasting Serum C-Peptide Ratio is a Predictor of Response to Basal Insulin-Supported Oral Antidiabetic Drug(s) Therapy: A Retrospective Analysis

  2018cites this paper
• The comparison of two glucose measurement systems: POCT devices versus central laboratory

  2018cites this paper
• The safety and efficacy of once-weekly glucagon-like peptide-1 receptor agonist semaglutide in patients with type 2 diabetes mellitus: a systemic review and meta-analysis

  2018cites this paper
• Waist–thigh Ratio: A Surrogate Marker for Type 2 Diabetes Mellitus in Asian North Indian Patients

  2018cites this paper
• Type 2 Diabetes Mellitus, Impaired Glucose Tolerance and Associated Comorbidities in Children During 2002–2013 in Children’s Clinical University Hospital, Latvia

  2018cites this paper
• Prevalence of type 2 diabetes mellitus in Southern Cross River: a cross-sectional observational survey

  2018cites this paper
• Predictors of poor glycemic control in type 2 diabetic patients in South Indian population

  2018cites this paper
• Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats

  2018cites this paper
• Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial

  2018cites this paper
• Typ-2-Diabetes – Kriterien für die Wahl des Antidiabetikums

  2018cites this paper
• Treatment approach to type 2 diabetes: Past, present and future

  2018cites this paper
• Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials

  2017cites this paper
• Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights.

  2017cites this paper
• Laboratory Diagnosis of HbA1c: A Review

  2017cites this paper
• Amelioration of hyperglycaemia and modulation of antioxidant status by Alcea rosea seeds in alloxan-induced diabetic rats

  2017cites this paper
• The Emergence of Sodium glucose Co-transporter 2 Inhibitors as a Successful Agent for Management of Diabetes Mellitus

  2017cites this paper
• Sitagliptin–Moringa oleifera coadministration did not delay the progression nor ameliorated functional and morphological anomalies in alloxan-induced diabetic nephropathy

  2017cites this paper
• Efficacy of low carbohydrate diet for type 2 diabetes mellitus management: A systematic review and meta-analysis of randomized controlled trials.

  2017cites this paper
• A meta‐analysis comparing clinical effects of short‐ or long‐acting GLP‐1 receptor agonists versus insulin treatment from head‐to‐head studies in type 2 diabetic patients

  2017cites this paper
• The use of smartphone health apps and other mobile health (mHealth) technologies in dietetic practice: a three country study

  2017cites this paper
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

  2017cites this paper
• Blood Glucose Concentration Management in Neuro-Patients

  2017cites this paper
• Guía de Práctica Clínica (GPC) para el diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 1 en la población mayor de 15 años

  2017cites this paper
• Simultaneous evaluation of fetal cerebrovascular Doppler ultrasound and maternal glucose homeostasis in normal pregnancy

  2017cites this paper
• Validation of automated screening for referable diabetic retinopathy with the IDx‐DR device in the Hoorn Diabetes Care System

  2017cites this paper
• CONCENTRATED INSULINS: CLINICAL APPLICATIONS & USE IN PRACTICAL SETTINGS.

  2017cites this paper
• Reduction of postprandial glucose by lixisenatide vs sitagliptin treatment in Japanese patients with type 2 diabetes on background insulin glargine: A randomized phase IV study (NEXTAGE Study)

  2017cites this paper
• A retrospective study on the clinical characteristics of patients with growth-hormone adenoma

  2017cites this paper
• Role of conventional oral antidiabetic drugs in management of type 2 diabetes mellitus

  2017cites this paper
• Body Mass Index-Related Mortality in Patients with Type 2 Diabetes and Heterogeneity in Obesity Paradox Studies: A Dose-Response Meta-Analysis

  2017cites this paper
• Knowledge of type 2 diabetic patients about their condition in Kimpese Hospital diabetic clinic, Democratic Republic of the Congo

  2017cites this paper
• Intraoperative Tight Glucose Control Using Hyperinsulinemic Normoglycemia Increases Delirium after Cardiac Surgery

  2017cites this paper
• A study evaluating the postprandial plasma glucose control among type 2 diabetes patients attending a teaching hospital in Malaysia.

  2017cites this paper
• Experience with Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes in Kuwait

  2017cites this paper
• Hyperglycemia in critical patients: Determinants of insulin dose choice.

  2017cites this paper
• Antihyperglycemic and Metabolic Effects of Ranolazine in Patients With Diabetes Mellitus.

  2017cites this paper
• Structured self‐monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS

  2017cites this paper
• Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial.

  2017cites this paper
• Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial.

  2017cites this paper
• Management of Diabetic Surgical Patients in a Deployed Field Hospital: A Model for Acute Non-Communicable Disease Care in Disaster

  2017cites this paper
• Patients’ attitudes to the use of modern technologies in the treatment of diabetes

  2016cites this paper
• Honey as a Sole Treatment of Type 2 Diabetes Mellitus

  2016cites this paper
• Lifestyle intervention strategies for diabetes management

  2016cites this paper
• State-level Legislative Efforts to Improve Diabetes Care and thereby Mitigate

  2016cites this paper
• Hypoglycemia Incidence Rates and Associated Health Care Costs in Patients with Type 2 Diabetes Mellitus Treated with Second-Line Linagliptin or Sulfonylurea After Metformin Monotherapy

  2016cites this paper